Giorgio Walter Canonica
A5030629710- Asthma and respiratory diseases
- Allergic Rhinitis and Sensitization
- Respiratory and Cough-Related Research
- Food Allergy and Anaphylaxis Research
- Dermatology and Skin Diseases
- Inhalation and Respiratory Drug Delivery
- Urticaria and Related Conditions
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Contact Dermatitis and Allergies
- Eosinophilic Esophagitis
- Olfactory and Sensory Function Studies
- IL-33, ST2, and ILC Pathways
- Pediatric health and respiratory diseases
- Sinusitis and nasal conditions
- Immune Cell Function and Interaction
- Delphi Technique in Research
- Ocular Surface and Contact Lens
- T-cell and B-cell Immunology
- Autoimmune Bullous Skin Diseases
- Pharmaceutical studies and practices
- Drug-Induced Adverse Reactions
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Monoclonal and Polyclonal Antibodies Research
- Mast cells and histamine
- Cell Adhesion Molecules Research
Humanitas University
2016-2025
IRCCS Humanitas Research Hospital
2017-2025
University of Foggia
2024-2025
Ospedale Policlinico San Martino
2012-2024
Sanofi (France)
2021-2024
Polyclinic Medical Center
2024
University of Milan
1991-2024
GlaxoSmithKline (India)
2024
Medical University of Warsaw
2024
Novartis (France)
2024
Abstract This evidence‐ and consensus‐based guideline was developed following the methods recommended by Cochrane Grading of Recommendations Assessment, Development Evaluation ( GRADE ) working group. The conference held on 1 December 2016. It is a joint initiative Dermatology Section European Academy Allergology Clinical Immunology EAACI ), EU ‐founded network excellence, Global Allergy Asthma Network GA ² LEN Forum EDF World Organization WAO with participation 48 delegates 42 national...
Abstract This guideline is the result of a systematic literature review using ‘ G rading R ecommendations A ssessment, D evelopment and E valuation’ ( GRADE ) methodology structured consensus conference held on 28 29 November 2012, in B erlin. It joint initiative ermatology S ection uropean cademy llergy C linical I mmunology EAACI ), EU ‐funded network excellence, lobal sthma N etwork GA 2 LEN F orum EDF W orld O rganization WAO with participation delegates 21 national international...
Patients with severe persistent asthma who are inadequately controlled despite Global Initiative for Asthma (GINA) 2002 step 4 therapy a challenging population significant unmet medical need. We determined the effect of omalizumab on clinically exacerbations (requiring systemic corticosteroids) in first study to exclusively enrol patients from this difficult-to-treat patient population.Following run-in phase, (12-75 years) high-dose inhaled corticosteroids (ICS) and long-acting...
This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev‐Jensen C, Canonica GW, Church MK, Giménez‐Arnau AM et al. EAACI/GA²LEN/EDF/WAO Guideline: Management urticaria. Allergy, 2009; 64 :1427–1443] is result a consensus reached during panel discussion at 3rd International Consensus Meeting Urticaria, Urticaria 2008 , joint initiative Dermatology Section European Academy Allergology and Clinical Immunology (EAACI), EU‐funded network...
To cite this article: Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, PJ, Burney PG, Canonica GW, Carlsen KH, Cox Haahtela T, Lodrup KC, Price D, Samolinski B, Simons FER, Wickman M, Annesi‐Maesano I, Baena‐Cagnani CE, Bergmann Bindslev‐Jensen Casale TB, Chiriac A, Cruz AA, Dubakiene R, Durham SR, Fokkens WJ, Gerth‐van‐Wijk Kalayci O, Kowalski ML, Mari Mullol Nazamova‐Baranova O’Hehir RE, Ohta K, Panzner P, Passalacqua G, Ring Rogala Romano Ryan Schmid‐Grendelmeier Todo‐Bom Valenta...
We have prepared this document, "Sublingual Immunotherapy: World Allergy Organization Position Paper 2013 Update", according to the evidence-based criteria, revising and updating chapters of originally published paper, 2009", available at http://www.waojournal.org. Namely, these comprise: "Mechanisms sublingual immunotherapy;" "Clinical efficacy immunotherapy" - reporting all data controlled trials after 2009; "Safety with recently Grading System for adverse reactions; "Impact immunotherapy...
This guideline, together with its sister guideline on the classification of urticaria (Zuberbier T, Asero R, Bindslev‐Jensen C, Canonica GW, Church MK, Giménez‐Arnau AM et al. EAACI/GA²LEN/EDF/WAO Guideline: definition, and diagnosis urticaria. Allergy 2009; 64 : 1417–1426), is result a consensus reached during panel discussion at Third International Consensus Meeting Urticaria, Urticaria 2008 , joint initiative Dermatology Section European Academy Allergology Clinical Immunology (EAACI),...
Critical examination of the quality and validity available allergic rhinitis (AR) literature is necessary to improve understanding appropriately translate this knowledge clinical care AR patient. To evaluate existing literature, international multidisciplinary experts with an interest in have produced International Consensus statement on Allergy Rhinology: Allergic Rhinitis (ICAR:AR).Using previously described methodology, specific topics were developed relating AR. Each topic was assigned a...
The perceptions of patients and physicians regarding the symptoms impact allergic rhinitis (AR) were assessed in a prospective, cross-sectional, international survey. This paper presents combined survey results from five European countries (Germany, France, Italy, Spain UK).Data recorded by 1,482 matched with records 415 primary care specialists. Diagnostic tests to confirm AR had been performed on 1,279 (86.3%) patients. Both presence, severity at time consultation addition those...
Background Prevalence of allergic diseases in infants, whose parents and siblings do not have allergy, is approximately 10% reaches 20–30% those with an first-degree relative. Intestinal microbiota may modulate immunologic inflammatory systemic responses and, thus, influence development sensitization allergy. Probiotics been reported to immune their supplementation has proposed as a preventive intervention.Objective The World Allergy Organization (WAO) convened guideline panel develop...
Currently, testing for immunoglobulin E (IgE) sensitization is the cornerstone of diagnostic evaluation in suspected allergic conditions. This review provides a thorough and updated critical appraisal most frequently used tests, both